Nebraska Officials Consider Changes To Medical Marijuana Rules

Nebraska medical cannabis regulators are reviewing proposed amendments to their regulations, including one that would remove the federal Schedule I controlled substance designation from product labels. This change reflects the evolving federal landscape surrounding cannabis reclassification. Public comment is being accepted both in-person and in writing, allowing patients and stakeholders to weigh in on how the state's medical cannabis program operates. The proposed modifications aim to align Nebraska's labeling requirements with potential federal policy changes, which could impact how medical cannabis is presented to patients seeking therapeutic options.